EI-ASMs are commonly used in sub-Saharan Africa. Despite concurrent use of EI-ASMs and ARVs, the majority of participants showed CD4 counts >200 cells/mm³ and were virally suppressed. Carbamazepine was not associated with an increased risk of virological failure or ARV-resistant HIV.
No takes yet. Share an insight, caveat, or question.
Navis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: